Schonfeld Strategic Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-21,469
| Closed | -$2.06M | – | 2478 |
|
|
2025
Q4 | $2.06M | Sell |
21,469
-146,689
| -87% | -$14.2M | 0.01% | 863 |
|
|
2025
Q3 | $16M | Buy |
168,158
+45,888
| +38% | +$4.22M | 0.09% | 232 |
|
|
2025
Q2 | $10.7M | Buy |
122,270
+105,820
| +643% | +$8.97M | 0.07% | 321 |
|
|
2025
Q1 | $1.48M | Sell |
16,450
-125,239
| -88% | -$11.2M | 0.01% | 1114 |
|
|
2024
Q4 | $11.3M | Sell |
141,689
-74,500
| -34% | -$6.45M | 0.07% | 271 |
|
|
2024
Q3 | $19.5M | Buy |
216,189
+100,117
| +86% | +$8.42M | 0.13% | 145 |
|
|
2024
Q2 | $9.14M | Buy |
116,072
+106,494
| +1,112% | +$8.73M | 0.06% | 372 |
|
|
2024
Q1 | $835K | Buy |
+9,578
| New | +$817K | 0.01% | 1300 |
|
|
2023
Q4 | – | Sell |
-20,986
| Closed | -$1.64M | – | 2075 |
|
|
2023
Q3 | $1.64M | Sell |
20,986
-103,794
| -83% | -$8.69M | 0.01% | 881 |
|
|
2023
Q2 | $11M | Buy |
124,780
+94,487
| +312% | +$8.13M | 0.09% | 321 |
|
|
2023
Q1 | $2.44M | Sell |
30,293
-415,708
| -93% | -$33.9M | 0.02% | 637 |
|
|
2022
Q4 | $34.7M | Buy |
446,001
+188,405
| +73% | +$15.3M | 0.29% | 72 |
|
|
2022
Q3 | $20.8M | Buy |
257,596
+17,857
| +7% | +$1.6M | 0.17% | 156 |
|
|
2022
Q2 | $21.5M | Buy |
239,739
+229,739
| +2,297% | +$23.3M | 0.21% | 121 |
|
|
2022
Q1 | $1.11M | Sell |
10,000
-46,150
| -82% | -$4.88M | 0.01% | 935 |
|
|
2021
Q4 | $5.81M | Sell |
56,150
-5,840
| -9% | -$676K | 0.05% | 423 |
|
|
2021
Q3 | $7.77M | Buy |
61,990
+8,690
| +16% | +$1.12M | 0.08% | 318 |
|
|
2021
Q2 | $6.62M | Sell |
53,300
-50,933
| -49% | -$6.4M | 0.07% | 390 |
|
|
2021
Q1 | $12.3M | Buy |
104,233
+94,133
| +932% | +$11M | 0.15% | 186 |
|
|
2020
Q4 | $1.18M | Sell |
10,100
-167,768
| -94% | -$18.5M | 0.02% | 754 |
|
|
2020
Q3 | $18.5M | Buy |
177,868
+65,188
| +58% | +$6.55M | 0.35% | 49 |
|
|
2020
Q2 | $10.3M | Buy |
112,680
+65,273
| +138% | +$6.26M | 0.27% | 91 |
|
|
2020
Q1 | $4.28M | Sell |
47,407
-77,415
| -62% | -$8.24M | 0.27% | 81 |
|
|
2019
Q4 | $14.2M | Buy |
124,822
+3,618
| +3% | +$397K | 0.35% | 69 |
|
|
2019
Q3 | $13.2M | Buy |
121,204
+6,730
| +6% | +$702K | 0.39% | 78 |
|
|
2019
Q2 | $11.1M | Buy |
114,474
+32,374
| +39% | +$2.96M | 0.39% | 60 |
|
|
2019
Q1 | $7.48M | Buy |
82,100
+32,100
| +64% | +$2.87M | 0.26% | 104 |
|
|
2018
Q4 | $4.55M | Buy |
+50,000
| New | +$4.67M | 0.17% | 163 |
|
|
2017
Q1 | – | Sell |
-18,213
| Closed | -$1.3M | – | 680 |
|
|
2016
Q4 | $1.3M | Buy |
+18,213
| New | +$1.43M | 0.17% | 186 |
|
|
2016
Q2 | – | Sell |
-20,323
| Closed | -$1.52M | – | 490 |
|
|
2016
Q1 | $1.52M | Buy |
+20,323
| New | +$1.53M | 0.62% | 33 |
|
Other funds holding MDT
VCM
VPM
Schonfeld Strategic Advisors's MDT Position: Q1 2026 in Review
Schonfeld Strategic Advisors sold out of Medtronic (MDT) in Q1 2026, closing a stake of 21,469 shares — an estimated $2.06M sold.
Schonfeld Strategic Advisors first reported a position in MDT in Q1 2016 and held it in 30 quarters. The position peaked at $34.7M in Q4 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Schonfeld Strategic Advisors reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 21,469 Medtronic shares in Q1 2026, an estimated $2.06M.
- Schonfeld Strategic Advisors first reported a position in Medtronic in Q1 2016 and held it in 30 quarters.
- Schonfeld Strategic Advisors's Medtronic position peaked at $34.7M in Q4 2022.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.